Literature DB >> 12467625

N,N-disubstituted piperazines: synthesis and affinities at alpha4beta2(*) and alpha7(*) neuronal nicotinic acetylcholine receptors.

Jianhong Chen1, Seth Norrholm, Linda P Dwoskin, Peter A Crooks, Donglu Bai.   

Abstract

A series of N,N-disubstituted piperazines were prepared and evaluated for binding to alpha4beta2(*) and alpha7(*) neuronal nicotinic acetylcholine receptors using rat striatum and whole brain membrane preparations, respectively. This series of compounds exhibited selectivity for alpha4beta2(*) nAChRs and did not interact with the alpha7(*) nAChRs subtype. The most potent analogues were compounds 8b and 8f (K(i)=32 microM). Thus, linking together a pyridine pi-system and a cyclic amine moiety via a piperazine ring affords compounds with low affinity, but good selectivity for alpha4beta2(*) nicotinic receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12467625      PMCID: PMC3749776          DOI: 10.1016/s0960-894x(02)00849-1

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  31 in total

Review 1.  Exploring the nature of molecular recognition in nicotinic acetylcholine receptors.

Authors:  J D Schmitt
Journal:  Curr Med Chem       Date:  2000-08       Impact factor: 4.530

Review 2.  Central nicotinic receptor ligands and pharmacophores.

Authors:  R A Glennon; M Dukat
Journal:  Pharm Acta Helv       Date:  2000-03

Review 3.  Neuronal nicotinic acetylcholine receptors as novel drug targets.

Authors:  G K Lloyd; M Williams
Journal:  J Pharmacol Exp Ther       Date:  2000-02       Impact factor: 4.030

4.  Synthesis and binding studies of some epibatidine analogues.

Authors:  S Rádl; P Hezký; W Hafner; M Budesínský; L Hejnová
Journal:  Bioorg Med Chem Lett       Date:  2000-01-03       Impact factor: 2.823

5.  Hybridized and isosteric analogues of N1-acetyl-N4-dimethyl-piperazinium iodide (ADMP) and N1-phenyl-N4-dimethyl-piperazinium iodide (DMPP) with central nicotinic action.

Authors:  D Manetti; A Bartolini; P A Borea; C Bellucci; S Dei; C Ghelardini; F Gualtieri; M N Romanelli; S Scapecchi; E Teodori; K Varani
Journal:  Bioorg Med Chem       Date:  1999-03       Impact factor: 3.641

6.  TC-2559: a novel orally active ligand selective at neuronal acetylcholine receptors.

Authors:  M Bencherif; A J Bane; C H Miller; G M Dull; G J Gatto
Journal:  Eur J Pharmacol       Date:  2000-12-01       Impact factor: 4.432

Review 7.  The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents.

Authors:  G K Lloyd; F Menzaghi; B Bontempi; C Suto; R Siegel; M Akong; K Stauderman; G Velicelebi; E Johnson; M M Harpold; T S Rao; A I Sacaan; L E Chavez-Noriega; M S Washburn; J M Vernier; N D Cosford; L A McDonald
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

8.  Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors.

Authors:  M W Holladay; J T Wasicak; N H Lin; Y He; K B Ryther; A W Bannon; M J Buckley; D J Kim; M W Decker; D J Anderson; J E Campbell; T A Kuntzweiler; D L Donnelly-Roberts; M Piattoni-Kaplan; C A Briggs; M Williams; S P Arneric
Journal:  J Med Chem       Date:  1998-02-12       Impact factor: 7.446

9.  Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors.

Authors:  A R Davies; D J Hardick; I S Blagbrough; B V Potter; A J Wolstenholme; S Wonnacott
Journal:  Neuropharmacology       Date:  1999-05       Impact factor: 5.250

10.  Synthesis and structure-activity relationship of novel pyridyl ethers for the nicotinic acetylcholine receptor.

Authors:  J Lee; C B Davis; R A Rivero; A B Reitz; R P Shank
Journal:  Bioorg Med Chem Lett       Date:  2000-05-15       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.